v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue:    
Revenue $ 320 $ 0
Operating expenses:    
Research and development 6,601 6,096
Impairment of intangible assets 0 9,703
General and administrative 6,324 11,442
Total operating expenses 12,925 27,241
Loss from operations (12,605) (27,241)
Other income (expense)    
Interest income 801 533
Interest expenses (185) (653)
Foreign exchange gains (losses) 757 (212)
Change in fair value adjustment of warrant derivative liabilities 1 2,677
Total other income 1,374 2,345
Loss before income tax expense (benefit) (11,231) (24,896)
Income tax expense (benefit) 0 (381)
Net loss (11,231) (24,515)
Net loss attributable to common stockholders $ (11,231) $ (25,154)
Net loss per common share, basic and diluted (in dollars per share) $ (0.78) $ (15.65)
Weighted average common shares outstanding, basic and diluted (in shares) 14,378,942 1,606,989
Net loss $ (11,231) $ (24,515)
Change in cumulative translation adjustment (667) 57
Total comprehensive loss (11,898) (24,458)
Series A Preferred Stock [Member]    
Other income (expense)    
Deemed dividends on Preferred Stock 0 (299)
Gain on extinguishment of Series A Preferred Stock 0 222
Redeemable Series A Convertible Preferred Stock [Member]    
Other income (expense)    
Deemed dividends on Preferred Stock 0 (562)
License [Member]    
Revenue:    
Revenue $ 320 $ 0